Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications.
Kis
B
B
Department of Psychiatry & Psychotherapy, University of Duisburg-Essen, Virchow Street 174, 45147 Essen, Germany. bernhard.kis@uni-duisburg-essen.de
Hedrich
K
K
Kann
M
M
Schwinger
E
E
Kömpf
D
D
Klein
C
C
Pramstaller
P P
PP
D017668:Age of Onset; D000978:Antiparkinson Agents / Q000009:adverse effects; D001058:Apomorphine / Q000494:pharmacology; D001479:Basal Ganglia / Q000473:pathology / Q000503:physiopathology*; D002114:Calcinosis / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D020821:Dystonic Disorders / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D008875:Middle Aged; D015835:Ocular Motility Disorders / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D009801:Oculomotor Muscles / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000150:complications / Q000473:pathology / Q000503:physiopathology*
D000978:Antiparkinson Agents; D007980:Levodopa; D001058:Apomorphine